Symbiotics is the leading market access platform for impact investing. Over the past decade, the company has originated and structured nearly 3500 investment transactions, worth more than USD 4.4 billion, on behalf of more than 700 companies in approximately 80 emerging and frontier markets, all serving a measurable sustainable and inclusive finance objective, purchased by 50 different investment funds and institutional investors. Symbiotics is a registered asset manager in Switzerland, a registered investment adviser in the United Kingdom, and has further office presence in Mexico, the Netherlands, Singapore and South Africa, regrouping more than 140 employees worldwide.
Through its new online platform Plumseeds.com, for professional investors seeking impact investments in emerging markets, Symbiotics believes in being transparent about the financial benefits, the social impact and the associated risks. That way, qualified investors can make an informed investment decision and build their own impact investment portfolio.
Symbiotics has developed three complementary and independent value propositions, covering the full investment intermediation value chain: Market Research, Asset Management and Investment Advisory.
All of these offerings suit the different needs of socially responsible investors wishing to reach out through investments to micro-, small and medium enterprises and low income households. Our clients use our services at different levels of intensity, depending on their own strategy, organization and processes.
We work with domestic financial institutions which focus on micro-, small and medium enterprises and low income households with the aim of fostering job creation and access to goods of first necessity. By broadening and deepening the access to capital to microfinance institutions as well as other financial institutions such as SME banks, leasing and factoring companies, to finance an array of Symbiotics is driven by four core themes, that will be further developed in the coming years: